From: The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery
Number of units (median, IQR)
Type of transfusion
TA group (n = 1543)
NTA Group (n = 427)
p value
RBC
2 (1,4)
3 (1,5)
0.228
FFP
0 (0,0)
0.117
Total blood products
3 (2,6)
0.289